NCT03198585View on ClinicalTrials.gov

Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction

PHASE2CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

June 29, 2017

Primary Completion Date

December 20, 2019

Study Completion Date

January 17, 2020

Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
DRUG

Empagliflozin 10 MG

Capsule, once a day for 90 days

OTHER

Placebo

Capsule, once a day for 90 days

Trial Locations (2)

2730

Herlev and Gentofte University Hospital, Copenhagen

5000

Odense University Hospital, Odense

All Listed Sponsors
lead

Morten Schou

OTHER

NCT03198585 - Empagliflozin in Heart Failure Patients With Reduced Ejection Fraction | Biotech Hunter | Biotech Hunter